Mobile Guide 2011

There is little doubt that mobile has finally reached its tipping point in the healthcare space. Enabled by the emergence and adoption of smart phone technology, and the subsequent arrival of tablet devices, mobile has quickly become an integral part of the fabric of healthcare communications. Now all that remains is for marketers to unlock the huge potential it promises. Desperate not to be left behind, pharma companies are dipping toes in the experimental waters of consumer apps, but is in the professional arena where most of the attention—and dollars—are currently being directed. Physicians' love affair with smart devices, namely iPhones and iPads, shows little sign of abating and marketers are following the buzz. Click here to find the Mobile Guide in its entirety. You'll find tips for how to successfully go mobile, as well as plenty of trends, data and insights to help maximize these opportunities.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.